Literature DB >> 29788899

Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.

Navjot Kaur1, Kusha Sharma1, Neena Bedi1.   

Abstract

OBJECTIVE: The aim of the present study was to develop and evaluate nanostructured lipid carrier based topical hydrogel of mometasone furoate for the treatment of psoriasis.
METHOD: Drug loaded NLCs were successfully developed by microemulsion technique. Pseudo ternary phase diagrams were constructed using different combinations of surfactant and co-surfactants to study the microemulsion existence range. Different compositions were selected from the phase diagram showing maximum microemulsion region and were converted into NLCs by dilution in water (1:20). The optimized formulation was characterised for droplet size, zeta potential, entrapment efficiency and morphology was studied using Transmission Electron Microscopy. Ex vivo permeation studies were carried out using Wistar rat skin. The potential of this formulation in treating psoriatic inflammation was studied using imiquimod induced skin inflammation animal model.
RESULTS: The optimized formulation (F4) has droplet size of 163.2±0.522 nm, zeta potential - 0.086±0.099 mV and entrapment efficiency of 60.0±0.187%. Transmission electron microscopy confirmed spherical shape of nanostructured lipid carrier. Carbopol 940 was used to convert NLC dispersion into NLC based hydrogel to improve its viscosity for topical administration. Drug permeation studies showed prolonged drug release from the NLC based gel as compared to marketed formulation following Higuchi release kinetics. The skin deposition of MF loaded NLC based hydrogel was found to 2.5 fold higher than marketed formulation with primary skin irritation index of 0.20. In vivo studies showed complete clearance of parakeratosis by treatment with the prepared NLC formulation. Accelerated stability studies signify high robustness scale of optimized formulation under one month storage period.
CONCLUSION: The prepared NLC based formulation has proved to be a promising carrier system for the treatment of psoriasis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Hydrogel; microemulsion technique; mometasone furoate; nanostructured lipid carriers; psoriasis; topical delivery.

Mesh:

Substances:

Year:  2018        PMID: 29788899     DOI: 10.2174/2211738506666180523112513

Source DB:  PubMed          Journal:  Pharm Nanotechnol        ISSN: 2211-7385


  9 in total

Review 1.  Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review.

Authors:  Martyna Zagórska-Dziok; Marcin Sobczak
Journal:  Pharmaceutics       Date:  2020-04-26       Impact factor: 6.321

2.  A Poly (Caprolactone)-Cellulose Nanocomposite Hydrogel for Transdermal Delivery of Hydrocortisone in Treating Psoriasis Vulgaris.

Authors:  Pierre P D Kondiah; Thankhoe A Rants'o; Sipho Mdanda; Lauwrence M Mohlomi; Yahya E Choonara
Journal:  Polymers (Basel)       Date:  2022-06-28       Impact factor: 4.967

Review 3.  Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects.

Authors:  Ummu Umaimah Mohd Nordin; Noraini Ahmad; Norazlinaliza Salim; Nor Saadah Mohd Yusof
Journal:  RSC Adv       Date:  2021-09-01       Impact factor: 4.036

Review 4.  Treatment of Psoriasis: Novel Approaches to Topical Delivery.

Authors:  Uwe Wollina; Michael Tirant; Aleksandra Vojvodic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-08-30

Review 5.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

Review 6.  Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review.

Authors:  Agnieszka Kulawik-Pióro; Małgorzata Miastkowska
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 7.  Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.

Authors:  Salma A Fereig; Ghada M El-Zaafarany; Mona G Arafa; Mona M A Abdel-Mottaleb
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

8.  Development and In Vitro/In Vivo Evaluation of pH-Sensitive Polymeric Nanoparticles Loaded Hydrogel for the Management of Psoriasis.

Authors:  Muhammad Imran Asad; Dildar Khan; Asim Ur Rehman; Abdelhamid Elaissari; Naveed Ahmed
Journal:  Nanomaterials (Basel)       Date:  2021-12-17       Impact factor: 5.076

9.  Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study.

Authors:  Qing Luo; Jingjing Yang; Haohang Xu; Jieran Shi; Zhen Liang; Rui Zhang; Ping Lu; Guojuan Pu; Ningmin Zhao; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.